Deadly synthetic opioids linked to deaths across the country have been found in one major city for the first time, only weeks ...

Pacira BioSciences, Inc.’s PCRX share price has surged by 5.48%, which has investors questioning if this is right time to ...

New Hampshire depends on a mix of funding sources to pay for substance use services. Two key pools of money are the Opioid ...

Californians can now buy opioid reversal drugs directly from the state under a program aimed at making the life-saving ...

After briefly approaching overdose deaths as a health problem, the 'war on drugs' appears to be making a comeback.

Here's a look at how each federal party has been framing the toxic drug crisis and a fact check on some of their proposed policies.

Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused ...

MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...

This crisis doesn’t discriminate. It affects working parents, young people and seniors — many of whom end up dependent ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

Dane County locations will be offering free, safe, environmentally-friendly options to drop off your medications on April 26, ...